Skip to content
by Legal Desire
28 August 2026

Baker McKenzie Advises McKesson on its USD 2.25 Billion Acquisition of Precision Medicine Group

Advising firms

Deal team

14 lawyers named
LawyerFirmSeniorityPracticeOffice
Darcy Down Lead Baker McKenzie Partner M&A Not stated
Collin Stich Baker McKenzie Not stated Corporate / M&A Not stated
Angus Duncan Baker McKenzie Not stated Corporate / M&A Not stated
Adam Aft Baker McKenzie Not stated IP / Data Not stated
Keo McKenzie Baker McKenzie Not stated IP / Data Not stated
Robby Turner Baker McKenzie Not stated IP / Data Not stated
Lois Sheng Liu Baker McKenzie Not stated Regulatory Not stated
Jing Xu Baker McKenzie Not stated Regulatory Not stated
Kimberly Franko Baker McKenzie Not stated Employment Not stated
Benjamin Durst Baker McKenzie Not stated Employment Not stated
M'Alyssa Mecenas Baker McKenzie Not stated Compensation Not stated
Sesen Hailemichael Baker McKenzie Not stated Compensation Not stated
Jill Sparkman Baker McKenzie Not stated Compensation Not stated
Sarah Swain Baker McKenzie Not stated Real Estate Not stated

11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 2.25bn (USD 2.25 billion)
What the figure measures
Total transaction value
Client
Not stated
Counterparties
Precision Medicine Group, LLC (Target)